A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer

<div>BRCA2 mutations and OS by cancer type. (a) Breast cancer. (b) Ovarian cancer. (c) Prostate cancer.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer 

Figure 4 | A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer 